Alexander von Gabain obtained his PhD in Genetics at the University of Heidelberg and held a Post-doctorate position at the Stanford University. In the 1980s and 1990s, he was Associate Professor at the University of Umeå and at the Karolinska Institute in Stockholm, Sweden. In 1998, he founded Intercell AG and led the company as CEO until it was successfully floated on the Vienna Stock Exchange in 2005. In 2011 he re-entered the Company as member of the Supervisory Board and today is continuing in this position. His research interest is in the field of biomedical research and documented by a large number of publications, book chapters, edition of books and patents. He is Chair (leave of absence) of Microbiology at the Max Perutz Laboratories of the University of Vienna and the Medical University, and foreign Adjunct Professor at the Karolinska Institute, Stockholm, member of several professional organizations and serves on the boards of biotech and venture capital enterprises. In 2008, he was appointed to the Governing Board of the European Institute of Innovation and Technology (EIT), of which he is the Chairman since 2011. His achievements have been acknowledged by prestigious industrial awards, academic prizes, honourable memberships, including the Swedish Royal Academy of Engineering Science and latest the European Luminary Innovation award. Alexander von Gabain obtained his PhD in Genetics at the University of Heidelberg and held a Post-doctorate position at the Stanford University. In the 1980s and 1990s, he was Associate Professor at the University of Umeå and at the Karolinska Institute in Stockholm, Sweden. In 1998, he founded Intercell AG and led the company as CEO until it was successfully floated on the Vienna Stock Exchange in 2005. In 2011 he re-entered the Company as member of the Supervisory Board and today is continuing in this position. His research interest is in the field of biomedical research and documented by a large number of publications, book chapters, edition of books and patents. He is Chair (leave of absence) of Microbiology at the Max Perutz Laboratories of the University of Vienna and the Medical University, and foreign Adjunct Professor at the Karolinska Institute, Stockholm, member of several professional organizations and serves on the boards of biotech and venture capital enterprises. In 2008, he was appointed to the Governing Board of the European Institute of Innovation and Technology (EIT), of which he is the Chairman since 2011. His achievements have been acknowledged by prestigious industrial awards, academic prizes, honourable memberships, including the Swedish Royal Academy of Engineering Science and latest the European Luminary Innovation award.

Surgery and Medicine